Cases & Deals

Boca Pharmacal acquired by Endo Health for $225 million

Clients Boca Life Science Holdings, LLC and Boca Pharmacal, LLC

Jones Day advised Boca Life Science Holdings, LLC and Boca Pharmacal, LLC in regards to the sale of all the outstanding limited liability company membership interests of Boca Pharmacal, LLC to Generics International (US) Inc., an Endo Health Solutions' subsidiary, for $225 million in cash.